CVRx (CVRX) EBT Margin Growth (1y) (2021 - 2026)
CVRx (CVRX) EBT Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | -719.00 |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 687.00 |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 458.00 |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 88.00 |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 374.00 |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 343.00 |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 84.00 |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | -126.00 |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 165.00 |
| 10 | CVRx | 76.50 Mn | 11.91 Mn | 13.72 Mn | 1,906.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,906.00 |
| Mar 31, 2026 | 2,270.00 |
| Dec 31, 2025 | -455.00 |
| Sep 30, 2025 | 997.00 |
| Jun 30, 2025 | 1,001.00 |
| Mar 31, 2025 | 9,412.00 |
| Dec 31, 2024 | 1,074.00 |
| Sep 30, 2024 | -1,225.00 |
| Jun 30, 2024 | 381.00 |
| Mar 31, 2024 | -6,352.00 |
| Dec 31, 2023 | 6,572.00 |
| Sep 30, 2023 | 7,304.00 |
| Jun 30, 2023 | 9,731.00 |
| Mar 31, 2023 | 10,236.00 |
| Dec 31, 2022 | 14,184.00 |
| Sep 30, 2022 | 2,158.00 |
| Jun 30, 2022 | 34,787.00 |
| Mar 31, 2022 | 5,657.00 |
| Dec 31, 2021 | -12,635.00 |
| Sep 30, 2021 | 14,179.00 |